Substance
ID:349614
Names and Identifiers
IUPAC name
4,4-difluoro-N-[(1S)-3-[(1R,3S,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
IUPAC Traditional name
4,4-difluoro-N-[(1S)-3-[(1R,3S,5S)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
Synonyms
4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamideUK-427857Maraviroc
Properties
Product Information
Empirical Formula (Hill Notation)
C29H41F2N5O
Purity
≥98% (HPLC)
Safety Information
MSDS Link
Safety Statements
22-36
German water hazard class
1
Storage Temperature
room temp
European Hazard Symbols
Harmful (Xn)Risk Statements
48/22
Physical Property
Apperance
white powder
Optical Rotation
[α]-15/D
Solubility
DMSO: >30 mg/mL
Molecule Details
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Maraviroc is a CCR5 chemokine receptor antagonist, and antiretroviral entry inhibitor. Maraviroc inhibits HIV entry by blocking interaction of viral coat protein gp120 with the receptor.
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Maraviroc is a CCR5 chemokine receptor antagonist, and antiretroviral entry inhibitor. Maraviroc inhibits HIV entry by blocking interaction of viral coat protein gp120 with the receptor.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data